Looking to enhance your genomic data interpretation? Zetta Genomics offers expert consultation services to guide your research journey! #ExpertAdvice#GenomicInsights https://t.co/fzTfX6Yj9O contact us to learn more [email protected]
Meet Marta, Head of #Bioinformatics at Zetta! With experience from @GenomicsEngland she’s tackling advanced data analysis challenges. Her mission? To build a holistic solution for the evolving data landscape in genomics. https://t.co/zevLsQ879I #Genomics#Bioinformatics#BioTechX
At Zetta, we're working to unleash the power of #genomic data and revolutionise patient care for all.
Our CFO, Bryony Burrows, shares our vision for a world where all medicine is #precisionmedicine.
Explore our #leadership team: https://t.co/SbuTYIxtKd
Cambridge startup @zetta_genomics has moved into its global HQ in the city’s Regent Street. The move has been financed using a small part of the £2.5m in seed funding which Zetta secured in February from @ninacapital, APEX Medical and @UCamEnterprise. https://t.co/XbHdcT89qH
In an interview with @scwmagazine, our Founder and CTO explains how the architecture of OpenCB and XetaBase addresses common problems in #GenomicResearch and #PrecisionMedicine.
Read now: https://t.co/riFxiEOliF
Last week we appointed Mark Bailey as our new CEO.
His vision & 20+ years experience in healthcare and science will help Zetta on its journey to develop and scale a platform fit for the #precisionmedicine era. Welcome, Mark.
Read in @GenomeWeb: https://t.co/Ylmp6cUe2w
In June 2022, we made some important updates to XetaBase 1.2 🧬
This included making IVA more functionally complete, as well as adding functionality linked to #OpenCGA v2.4.0.
The full release notes are available on our website here: https://t.co/pDqK2x3psz
In May this year, we made some important updates to XetaBase 1.1.
This included major improvements to panel searches and the Genome Browser. The full release notes are available on our website here: https://t.co/eQ1fEQBCNz
#AWS#genomics#precisionmedicine
Nearly 1,000 people are here in person at #GERS2022 to discuss all things genomics. Breakout sessions starting now in cancer, rare disease, policy & initiatives, and emerging tech! You can still register to join the sessions online here - https://t.co/zfeMY8gjGp
Matthew Murray, Prof. Cellular & Molecular Pathology, @Cambridge_Uni , has inspiring stories from 100,000 Genomes Project. 1/3rd children's cancer cases cannot be identified molecularly. Full #genome sequencing can give clinicians confidence in diagnosis and treatment decisions.
We know #genomics studies need to recruit and use more #diverse genomes! @GenomicsEngland has the Diverse Data Initiative to address the gap. The quest for #genomic equity continues - and could have far reaching health benefits for the global population. #GERS2022#Bioinformatics
If you can't make it to the @GenomicsEngland Research Summit today, you can still join in the conversation from home at https://t.co/COzFK1PZiW
We've had some great discussions on the floor and with online attendees already!
#GERS2022
If we didn't get a chance to catch up at #GERS2022 today, why not connect with us on LinkedIn?
You can find us at Zetta Genomics Ltd https://t.co/GpYajSiB1g
Great sessions today at @GenomicsEngland Research Summit. To find out how you can utilise advanced data management systems for #precisionmedicine, connect on LinkedIn or contact us through our website: https://t.co/7yuOOC8ElP
#GERS2022
That's a wrap!
Thanks to our Zetta delegates who took part in today's event, and especially to @GenomicsEngland for making the Research Summit a reality.
#GERS2022